Marijuana for Trauma has one of the largest networks of cannabis clinics in Canada, representing more than 6% of all Canadian medical patients through the Knalysis software platform.
Knalysis data indicates that prescription amounts are slightly higher for men than women.
While prescription volumes may be similar, reasons behind prescriptions vary by gender, severity, and in combination.
While much of the attention about the Canadian cannabis market is focused on the rollout of its adult-use program, Canada’s medical market remains formidable.
Canada’s medical cannabis market is forecast to ring up CAD$1.24 billion (USD$980M) in 2018, increasing to CAD$2.35 billion (USD$1.87B) by 2025.
